Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Mizutani, Yukiko ^a   Sun, Hui ^a   Ohno, Yusuke ^a   Sassa, Takayuki ^a   Wakashima, Takeshi ^a   Obara, Mari ^a   Yuyama, Kohei ^a   Kihara, Akio ^a   Igarashi, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CELL PROTEIN; CERAMIDE; CERS3 PROTEIN; ELOVL4 PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SPHINGOSINE ACYLTRANSFERASE; ULTRA LONG CHAIN FATTY ACID; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; CERAMIDE SYNTHASE 3, HUMAN; ELOVL4 PROTEIN, HUMAN; EYE PROTEIN; FATTY ACID; MEMBRANE PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ENZYME ACTIVITY; EPIDERMAL PERMEABILITY BARRIER; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; KERATINOCYTE; LIPID LAMELLA; LIPOGENESIS; PERMEABILITY BARRIER; PROTEIN MODIFICATION; SKIN PERMEABILITY; STRATUM CORNEUM; UPREGULATION; BIOSYNTHESIS; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

CELL DIFFERENTIATION; CERAMIDES; EYE PROTEINS; FATTY ACIDS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; KERATINOCYTES; MEMBRANE PROTEINS; PPAR DELTA; PPAR-BETA; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SPHINGOSINE N-ACYLTRANSFERASE; UP-REGULATION;

EID: 84879515141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067317     Document Type: Article

References (35)

1. Fuchs E, Raghavan S, (2002) Getting under the skin of epidermal morphogenesis. Nat Rev Genet 3: 199-209.
2. Proksch E, Brandner JM, Jensen JM, (2008) The skin: an indispensable barrier. Exp Dermatol 17: 1063-1072.
3. Uchida Y, Holleran WM, (2008) Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 51: 77-87.
4. Elias PM, Menon GK, (1991) Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24: 1-26.
5. Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y, (2009) Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 91: 784-790.
6. Levy M, Futerman AH, (2010) Mammalian ceramide synthases. IUBMB Life 62: 347-356.
7. Kihara A, Mitsutake S, Mizutani Y, Igarashi Y, (2007) Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 46: 126-144.
8. Kihara A, (2012) Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem 152: 387-395.
9. Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, et al. (2008) Characterization of overall ceramide species in human stratum corneum. J Lipid Res 49: 1466-1476.
10. Stewart ME, Downing DT, (2001) The ω-hydroxyceramides of pig epidermis are attached to corneocytes solely through omega-hydroxyl groups. J Lipid Res 42: 1105-1110.
11. Marekov LN, Steinert PM, (1998) Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273: 17763-17770.
12. Mizutani Y, Kihara A, Igarashi Y, (2005) Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J 390: 263-271.
13. Mizutani Y, Kihara A, Igarashi Y, (2006) LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem J 398: 531-538.
14. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, et al. (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283: 5677-5684.
15. Mizutani Y, Kihara A, Chiba H, Tojo H, Igarashi Y, (2008) 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J Lipid Res 49: 2356-2364.
16. Jakobsson A, Westerberg R, Jacobsson A, (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45: 237-249.
17. Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, et al. (2010) ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci USA 107: 18439-18444.
18. Vasireddy V, Uchida Y, Salem N Jr, Kim SY, Mandal MN, et al. (2007) Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal death. Hum Mol Genet 16: 471-482.
19. McMahon A, Butovich IA, Mata NL, Klein M, Ritter R 3rd, et al (2007) Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis 13: 258-272.
20. Cameron DJ, Tong Z, Yang Z, Kaminoh J, Kamiyah S, et al. (2007) Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 3: 111-119.
21. Li W, Sandhoff R, Kono M, Zerfas P, Hoffmann V, et al. (2007) Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 3: 120-128.
22. Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, et al. (2008) Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci USA 105: 12843-12848.
23. Escher P, Wahli W, (2000) Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448: 121-138.
24. Braissant O, Wahli W, (1998) Differential expression of peroxisome proliferator-activated receptor-α,-β, and-γ during rat embryonic development. Endocrinology 139: 2748-2754.
25. Jiang YJ, Barish G, Lu B, Evans RM, Crumrine D, et al. (2010) PPARδ activation promotes stratum corneum formation and epidermal permeability barrier development during late gestation. J Invest Dermatol 130: 511-519.
26. Man MQ, Choi EH, Schmuth M, Crumrine D, Uchida Y, et al. (2006) Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol 126: 386-392.
27. Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, et al. (2008) Deficiency of PPARβ/δ in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 128: 370-377.
28. Hauptmann G, Gerster T, (1994) Two-color whole-mount in situ hybridization to vertebrate and Drosophila embryos. Trends Genet 10: 266.
29. Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, et al. (2012) Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 21: 586-608.
30. Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, et al. (2011) Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am J Hum Genet 89: 745-750.
31. Eckl KM, Tidhar R, Thiele H, Oji V, Hausser I, et al. (2013) Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermatol: in press.
32. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, et al. (2001) Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 116: 702-712.
33. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-β/δ stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122: 971-983.
34. Seo JB, Moon HM, Kim WS, Lee YS, Jeong HW, et al. (2004) Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor γ expression. Mol Cell Biol 24: 3430-3444.
35. Hong I, Rho HS, Kim DH, Lee MO, (2010) Activation of LXRα induces lipogenesis in HaCaT cells. Arch Pharm Res 33: 1443-1449.